Tourmaline Bio, Inc. (TRML)

NASDAQ: TRML · Real-Time Price · USD

14.24

-0.97 (-6.38%)

Apr 1, 2025, 4:00 PM EDT - Market closed

Tourmaline Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	366	520	532	-	-
Market Cap Growth	-2.33%	-2.33%	-	-	-
Enterprise Value	116	238	583	-	-
Last Close Price	15.21	20.28	26.18	-	-
PB Ratio	1.30	1.73	2.60	-	-
P/TBV Ratio	1.73	1.73	2.60	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.07	-0.66
Quick Ratio	28.99	28.99	40.57	6.06	0.40
Current Ratio	30.18	30.18	41.76	6.10	0.40
Return on Equity (ROE)	-28.99%	-28.99%	-39.66%	-549.77%	-
Return on Assets (ROA)	-21.60%	-21.60%	-25.87%	-266.29%	-
Return on Capital (ROIC)	-22.18%	-22.18%	-26.60%	-314.87%	-
Earnings Yield	-19.59%	-14.08%	-7.91%	-	-
FCF Yield	-20.68%	-14.86%	-5.29%	-	-
Buyback Yield / Dilution	-433.98%	-433.98%	-441.28%	91.94%	-

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q